D.E. Shaw & Co
STJ

D.E. Shaw & Co’s St Jude Medical STJ Stock Holding History

D.E. Shaw & Co’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-21,204
Closed -$1.7M – 3807
2016
Q4 		$1.7M Sell
21,204
-704,440
-97% -$55.9M ﹤0.01% 2111
2016
Q3 		$57.9M Sell
725,644
-719,573
-50% -$58.1M 0.1% 240
2016
Q2 		$113M Sell
1,445,217
-198,134
-12% -$14.1M 0.21% 106
2016
Q1 		$90.4M Buy
1,643,351
+1,536,052
+1,432% +$83.7M 0.16% 142
2015
Q4 		$6.63M Sell
107,299
-33,696
-24% -$2.13M 0.01% 1216
2015
Q3 		$8.89M Buy
140,995
+20,535
+17% +$1.47M 0.01% 1037
2015
Q2 		$8.8M Buy
120,460
+87,360
+264% +$6.31M 0.01% 1093
2015
Q1 		$2.17M Buy
33,100
+26,823
+427% +$1.78M ﹤0.01% 1948
2014
Q4 		$408K Sell
6,277
-525,303
-99% -$33.8M ﹤0.01% 3467
2014
Q3 		$32M Buy
531,580
+274,132
+106% +$17.9M 0.04% 483
2014
Q2 		$17.8M Sell
257,448
-351,463
-58% -$22.8M 0.02% 754
2014
Q1 		$39.8M Buy
+608,911
New +$39.6M 0.06% 365
2013
Q4 		– Sell
-48,161
Closed -$2.79M – 4840
2013
Q3 		$2.58M Buy
+48,161
New +$2.48M ﹤0.01% 2205

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

D.E. Shaw & Co's STJ Position: Q1 2017 in Review

D.E. Shaw & Co sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 21,204 shares — an estimated $1.7M sold.

D.E. Shaw & Co first reported a position in STJ in Q3 2013 and held it in 13 quarters. The position peaked at $113M in Q2 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • D.E. Shaw & Co reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 21,204 St Jude Medical shares in Q1 2017, an estimated $1.7M.
  • D.E. Shaw & Co first reported a position in St Jude Medical in Q3 2013 and held it in 13 quarters.
  • D.E. Shaw & Co's St Jude Medical position peaked at $113M in Q2 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on D.E. Shaw & Co's 13F filing for Q1 2017, filed 15 May 2017.